Efficiency of Bumetanide in Autistic Children

Study of the Efficiency of a Treatment by Bumetanide in a Population of Autistic Children

The purpose of this study is to determine if a treatment by bumetanide presents an efficiency at the level of the neuronal maturation in the autism

Inclusion Criteria:

• Children from 3 to 10 years old, answering the diagnosis of typical autism according to the diagnostic criteria of autism of the classification of the WHO ( CIM-10) and the parents of which gave a free, enlightened and written consent.

Exclusion Criteria:

• Patients epileptic autistics treated by anticomitiaux or having hurts of the central nervous system
• Patients autistics receiving a psychotropic treatment
• Patients presenting disorders electrolytes
• Patients presenting a hypersensibility known about sulpha drugs
• Presenting patients against indications relative to the treatment by bumetanide
• Patients already treated by diuretics
• Patients presenting a hepatic or renal incapacity
• Patients presenting an elongation of the QT to the electrocardiogram.
• Patients autistics of CARS sore is lower than 30.